Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001879
Filing Date
2024-11-12
Accepted
2024-11-12 16:10:53
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nwbo-20240930x10q.htm   iXBRL 10-Q 2403585
2 EX-31.1 nwbo-20240930xex31d1.htm EX-31.1 12503
3 EX-32.1 nwbo-20240930xex32d1.htm EX-32.1 9237
  Complete submission text file 0001410578-24-001879.txt   10878086

Data Files

Seq Description Document Type Size
4 EX-101.SCH nwbo-20240930.xsd EX-101.SCH 80370
5 EX-101.CAL nwbo-20240930_cal.xml EX-101.CAL 59723
6 EX-101.DEF nwbo-20240930_def.xml EX-101.DEF 348688
7 EX-101.LAB nwbo-20240930_lab.xml EX-101.LAB 554309
8 EX-101.PRE nwbo-20240930_pre.xml EX-101.PRE 482453
76 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20240930x10q_htm.xml XML 2256557
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 241448213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)